Suppr超能文献

亲属活体肾移植中多支动脉处理时肾副动脉与腹壁下动脉的序贯吻合术:一项批判性评估

Sequential anastomosis of accessory renal artery to inferior epigastric artery in the management of multiple arteries in live related renal transplantation: a critical appraisal.

作者信息

Kumar A, Gupta R S, Srivastava A, Bansal P

机构信息

Department of Urology and Renal Transplantation, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow (U.P.), India.

出版信息

Clin Transplant. 2001 Apr;15(2):131-5. doi: 10.1034/j.1399-0012.2001.150209.x.

Abstract

In live related renal transplant program, management of multiple renal arteries (MRA) is technically demanding and used to be considered a relative contraindication because of increased risk of vascular and urologic complications. We present a retrospective analysis of the outcome of grafts with MRA and suggest certain guidelines. Of the 680 live related kidney transplantations done, 53 allografts had MRA. Cases were grouped according to the reconstruction technique: group A, MRA reconstructed ex vivo into a single renal artery (n=27); group B, MRA with multiple anastomoses in vivo (n =13); group C, MRA with sequential revascularization using inferior epigastric artery (n=11). We compared serum creatinine, acute tubular necrosis, rejection rates and the rewarm ischemia time between the three groups. Overall patient survival and graft survival were excellent (100 and 96%). Mean serum creatinine at 1 yr did not differ significantly between the three groups. Rewarm ischemia time was significantly less in group C (p<0.01). Incidence of acute tubular necrosis and rejection episodes was also less in group C although the difference was statistically significant only between group C and group B. We conclude that allografts with MRA can be used successfully in a live related renal transplantation program. Bench reconstruction should be done whenever possible. For reconstruction of an accessory vessel, inferior epigastric artery with sequential revascularization is recommended.

摘要

在活体亲属肾移植项目中,处理多支肾动脉(MRA)技术要求高,且由于血管和泌尿系统并发症风险增加,过去曾被视为相对禁忌证。我们对有MRA的移植肾结果进行了回顾性分析并提出了某些指导原则。在完成的680例活体亲属肾移植中,53例移植肾有MRA。病例根据重建技术分组:A组,MRA在体外重建为单支肾动脉(n = 27);B组,MRA在体内进行多处吻合(n = 13);C组,MRA采用腹壁下动脉进行序贯血运重建(n = 11)。我们比较了三组之间的血清肌酐、急性肾小管坏死、排斥反应发生率及复温缺血时间。总体患者生存率和移植肾生存率极佳(分别为100%和96%)。三组之间1年时的平均血清肌酐无显著差异。C组的复温缺血时间显著更短(p<0.01)。C组急性肾小管坏死和排斥反应的发生率也更低,尽管仅C组与B组之间的差异有统计学意义。我们得出结论,有MRA的移植肾可成功用于活体亲属肾移植项目。应尽可能进行体外重建。对于副肾动脉的重建,推荐采用腹壁下动脉进行序贯血运重建。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验